The groundbreaking rise of Viagra has long been a benchmark of pharmaceutical success, yet its legacy within the broader industry now raises questions about future gains. Copycat versions are undercutting patent protection , leading to anxieties that supporting companies heavily reliant to Viagra's previous influence could be a problematic move , e